Consensus Purple Innovation, Inc.

Equities

PRPL

US74640Y1064

Market Closed - Nasdaq Other stock markets 01:30:00 03/05/2024 am IST			5-day change	1st Jan Change
1.6 ^USD	+2.56%		+6.67%	+55.34%

21/03	Purple Innovation Files Registration Statement for Secondary Offering	MT
13/03	Roth MKM Upgrades Purple Innovation to Buy From Neutral, Raises Price Target to $2.50 From $2	MT

Evolution of the average Target Price on Purple Innovation, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1960458e0485.K0gFx0Cz6tHvnHmIT4jwf977CjUHzSN38iwg6R0L8yQ.eHhrig6AormLzhf4HMOXG7fPOwI3uWEBu3wTmVJEm0VacHS9C_GCvJXSTQ~1d661dac31230bfafd9fb2923b2f7847

Analyst Recommendations on Purple Innovation, Inc.

Purple Innovation Files Registration Statement for Secondary Offering	22/03	MT
Roth MKM Upgrades Purple Innovation to Buy From Neutral, Raises Price Target to $2.50 From $2	13/03	MT
Craig-Hallum Adjusts Price Target on Purple Innovation to $2 From $1, Maintains Hold Rating	13/03	MT
UBS Adjusts Purple Innovation Price Target to $2 From $1, Maintains Neutral Rating	13/03	MT
Wedbush Adjusts Purple Innovation's Price Target to $2.25 From $1.25, Maintains Outperform Rating	13/03	MT
KeyBanc Adjusts Price Target on Purple Innovation to $5 From $6, Maintains Overweight Rating	24/01	MT
Oppenheimer Downgrades Purple Innovation to Perform From Outperform	13/11	MT
Craig-Hallum Downgrades Purple Innovation to Hold From Buy, Cuts Price Target to $1 From $4	10/11	MT
UBS Adjusts Purple Innovation Price Target to $0.80 From $2.75, Maintains Neutral Rating	10/11	MT
KeyBanc Adjusts Price Target on Purple Innovation to $6 From $8, Maintains Overweight Rating	10/11	MT
KeyBanc Adjusts Purple Innovation Price Target to $6 From $8, Maintains Overweight Rating	10/11	MT
Wedbush Lowers Purple Innovation's PT to $1 From $3 After Q3 Revenue, EBITDA Miss Expectations; Keeps Outperform Rating	10/11	MT
UBS Adjusts Purple Innovation Price Target to $2.75 From $3, Maintains Neutral Rating	10/23/10	MT
Wedbush Purple Innovation's PT to $3 From $3.50 After Q2 Miss, Notes Execution Risk, Lower Industry Demand Outlook; Keeps Outperform Rating	10/23/10	MT
UBS Adjusts Purple Innovation Price Target to $3 From $2.75, Maintains Neutral Rating	11/23/11	MT
Wedbush Trims Purple Innovation's Price Target to $3.50 From $5, Notes Execution Risk; Keeps Outperform Rating	11/23/11	MT
UBS Adjusts Purple Innovation Price Target to $2.75 From $6, Maintains Neutral Rating	21/23/21	MT
Wedbush Trims Purple Innovation's Price Target $5 From $6.75, Notes 'Tough' Q4, Start to 2023; Keeps Outperform Rating	17/23/17	MT
KeyBanc Capital Markets Adjusts Price Target on Purple Innovation to $8 From $7, Maintains Overweight Rating	01/23/01	MT
Wedbush Adjusts Purple Innovation's Price Target to $6.75 From $5, Maintains Outperform Rating	31/23/31	MT
UBS Adjusts Purple Innovation Price Target to $6 From $4.75, Maintains Neutral Rating	30/23/30	MT
Keybanc Adjusts Price Target on Purple Innovation to $7.50 From $5, Maintains Overweight Rating	12/23/12	MT
Craig-Hallum Upgrades Purple Innovation to Buy From Hold, Adjusts Price Target to $6 From $4	10/22/10	MT
UBS Adjusts Purple Innovation Price Target to $4.35 From $4, Maintains Neutral Rating	20/22/20	MT
Wedbush Lifts Price Target on Purple Innovation to $5 From $3.30 After Coliseum Offer, Keeps Outperform Rating	20/22/20	MT